Inoreal

Inoreal is a French biotechnology company specializing in the research, development, and commercialization of natural active ingredients derived from saffron (Crocus sativus). The company is best known for its flagship product, Satiereal, a clinically studied saffron extract used in dietary supplements for weight management, satiety, and emotional well-being. Inoreal focuses on high-quality extraction processes and clinical validation to support health claims related to mood and metabolic health. In early 2023, the company was acquired by Nexira, a global leader in natural ingredients, to strengthen its portfolio of premium botanical extracts. The company's expertise lies in identifying specific bioactive compounds within saffron that modulate neurotransmitters like serotonin to influence appetite and mood.